Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications

Shereen Ezzat1, Sonia Cheng1, Sylvia L Asa2

  • 1Department of Medicine, University of Toronto, The Endocrine Oncology Site Group, Princess Margaret Cancer Centre, and The Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.

Insights

Genetic mutations are rare in sporadic pituitary tumors. Epigenetic changes like DNA methylation and altered miRNA expression are key drivers, offering new therapeutic targets.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Sporadic pituitary tumors often lack common genetic mutations in oncogenes or tumor suppressor genes.
  • Epigenetic alterations are increasingly recognized as significant factors in pituitary tumor development.

Purpose of the Study:

  • To review evidence on epigenetic alterations in human sporadic pituitary tumors.
  • To elucidate the mechanisms of pituitary tumorigenesis driven by epigenetic changes.
  • To highlight potential therapeutic strategies based on these findings.

Main Methods:

  • Literature review of studies investigating epigenetic modifications in pituitary tumors.
  • Analysis of data on DNA methylation patterns.
  • Examination of histone modifications and microRNA (miRNA) expression profiles.

Main Results:

  • Frequent epigenetic alterations, including DNA methylation and histone modifications, are observed in sporadic pituitary tumors.
  • Enhanced microRNA (miRNA) expression is a common finding, suggesting its role in tumorigenesis.
  • These epigenetic changes provide insights into the molecular pathways driving tumor formation.

Conclusions:

  • Epigenetic dysregulation, rather than genetic mutations, is a primary mechanism in sporadic pituitary tumorigenesis.
  • Understanding these epigenetic alterations opens avenues for novel therapeutic interventions.
  • Targeting epigenetic modifications may offer a promising strategy for pituitary tumor treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K